Discontinued — last reported Q3 '23
Curtiss-Wright Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 3.9% to $49.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.0%, from $50.00M to $49.00M. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) shows relatively stable performance with a 0.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.00M | $45.00M | $45.00M | $44.00M | $51.00M | $51.00M | $53.00M | $50.00M | $50.00M | $50.00M | $50.00M | $44.00M | $45.00M | $45.00M | $50.00M | $50.00M | $51.00M | $51.00M | $51.00M | $49.00M |
| QoQ Change | — | -2.2% | +0.0% | -2.2% | +15.9% | +0.0% | +3.9% | -5.7% | +0.0% | +0.0% | +0.0% | -12.0% | +2.3% | +0.0% | +11.1% | +0.0% | +2.0% | +0.0% | +0.0% | -3.9% |
| YoY Change | — | — | — | — | +10.9% | +13.3% | +17.8% | +13.6% | -2.0% | -2.0% | -5.7% | -12.0% | -10.0% | -10.0% | +0.0% | +13.6% | +13.3% | +13.3% | +2.0% | -2.0% |